Vestland Pharma secures investment for novel salmon lice treatment



Norwegian biotech firm Vestland Pharma has secured NOK 12 million in funding from venture capital group Sarsia and seafood giant Coast Seafood to fast-track the launch of its new natural salmon lice treatment.



Source link

Related articles

Industry leaders unite to develop African aquaculture

Business leaders from 22 companies across the African...

CMFRI to run three-day live fish sale

The ICAR-Central Marine Fisheries Research Institute (CMFRI) will...

Robins McIntosh

Robins McIntosh reflects on a year that’s seen...

Akva steps up submersible salmon cage technology

Akva group has launched a next-generation air dome...